Allogene Therapeutics (ALLO) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.41
-0.37
-0.32
-0.28

Details

Expected EPS
-0.326522
Actual EPS
-0.28
Surprise EPS
0.05
Surprise Percent
+14.25%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.28 per share for Q1 2025.

0 Comments

Share your thoughts